Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DR26FT4CB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,074
Award facts
- Contract value 100% obligated
- $18,074.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) injectable medication in 3 mL vials, with a ceiling value of $18,074.40. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and the contract is scheduled for ultimate completion by November 19, 2025. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. As a prime contractor under the DLA's comprehensive global pharmaceutical support vehicle, the company supplies a wide range of pharmaceuticals, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Ozempic, a diabetes management medication, reflects the company's role in fulfilling federal medical supply requirements through competitive procurement and demonstrates its capability to deliver both specialty and brand-name medications to support military healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FT4CB?
SPE2DR26FT4CB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FT4CB worth?
The government has obligated $18,074 on SPE2DR26FT4CB.
Is contract SPE2DR26FT4CB an order under another contract?
Yes. SPE2DR26FT4CB is a delivery order under SPE2DR25D3201, an indefinite delivery contract.
Was contract SPE2DR26FT4CB competed?
The extent of competition for SPE2DR26FT4CB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award